Elevance Health Reports Second Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Elevance (ELV) PT Lowered to $350 at BofA Securities
July 17, 2025 12:10 PM EDTBofA Securities analyst Kevin Fischbeck lowered the price target on Elevance (NYSE: ELV) to $350.00 (from $420.00) while maintaining a Neutral rating.
The analyst comments "Despite a Q2 in-line with company expectations, ELV cut guidance by 13%, citing higher trend in exchanges... More
Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
July 17, 2025 6:02 AM EDTElevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.84, $0.23 worse than the analyst estimate of $9.07. Revenue for the quarter came in at $49.4 billion versus the consensus estimate of $48.14 billion.
GUIDANCE:
Elevance Health Inc. sees FY2025 EPS of $30.00, versus the consensus of... More
